Radiosensitivity enhancement by combined treatment of nimotuzumab and celecoxib on nasopharyngeal carcinoma cells
Jianfeng Huang,1,* Xiaopeng Yuan,2,* Qingfeng Pang,3 Haowen Zhang,4 Jiahua Yu,4 Bo Yang,1 Leyuan Zhou,1 Fuzheng Zhang,1 Fenju Liu4 1Department of Radiation Oncology, Affiliated Hospital of Jiangnan University, Wuxi, People’s Republic of China; 2Department of Radiation Oncology, Nantong Tum...
Saved in:
Main Authors: | Huang JF (Author), Yuan XP (Author), Pang QF (Author), Zhang HW (Author), Yu JH (Author), Yang B (Author), Zhou LY (Author), Zhang FZ (Author), Liu FJ (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2018-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Addition of nimotuzumab to concurrent chemoradiotherapy after induction chemotherapy improves outcomes of patients with locally advanced nasopharyngeal carcinoma
by: Run-Jie Wang, et al.
Published: (2024) -
IGF-1R Inhibition Suppresses Cell Proliferation and Increases Radiosensitivity in Nasopharyngeal Carcinoma Cells
by: Zhe Wang, et al.
Published: (2019) -
Afatinib Reverses EMT via Inhibiting CD44-Stat3 Axis to Promote Radiosensitivity in Nasopharyngeal Carcinoma
by: Huichao Huang, et al.
Published: (2022) -
In vitro and in vivo efficacy of afatinib as a single agent or in combination with gemcitabine for the treatment of nasopharyngeal carcinoma
by: Xue C, et al.
Published: (2016) -
Adverse events to the nimotuzumab in patients with primary cerebral tumor
by: Yasley Gámez Fernández, et al.
Published: (2022)